Trial · NCT02474407
Results by group145
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 145
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| AUC 0-24h | Single Dose of Diazapam Nasal Spray (DZNS) | 1357.7 | Standard Deviation 802.78 | ng*h/mL | |
| AUC 0-24h | Single Dose of Diazapam Rectal Gel (DRG) | 2117.9 | Standard Deviation 996.27 | ng*h/mL | |
| Cmax | Single Dose of Diazapam Nasal Spray (DZNS) | 157.0 | Standard Deviation 120.15 | ng/mL | |
| Cmax | Single Dose of Diazapam Rectal Gel (DRG) | 309.3 | Standard Deviation 137.95 | ng/mL | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - NONE | Nasal Irritation at Baseline - NONE | 64 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 1a | Nasal Irritation at Baseline - NONE | 6 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 1b | Nasal Irritation at Baseline - NONE | 0 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 2 | Nasal Irritation at Baseline - NONE | 1 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 3 | Nasal Irritation at Baseline - NONE | 0 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 4 | Nasal Irritation at Baseline - NONE | 0 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Missing | Nasal Irritation at Baseline - NONE | 0 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - NONE | Grade 1a | 1 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 1a | Grade 1a | 3 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 1b | Grade 1a | 0 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 2 | Grade 1a | 0 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 3 | Grade 1a | 0 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 4 | Grade 1a | 0 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Missing | Grade 1a | 0 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - NONE | Grade 1b | 0 | Participants | |
| Focused Nasal Exam (Part A) | DZNS - At 24 Hours Post-Dose - Grade 1a | Grade 1b | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02474407/results